« Return to News | CROs/Service Providers

Prometrika and Boston Biotech Clinical Research Help Sponsors Create DMCs

Tuesday, December 15, 2009 09:39 AM

Contract research organization (CRO) Prometrika and medical research consulting firm Boston Biotech Clinical Research (BBCR) are teaming up to provide data monitoring committee (DMC) services to clinical trial sponsors.  Together, the companies will help sponsors establish and operate independent DMCs (also called data safety monitoring boards and data and safety monitoring committees).

Sometimes required by the FDA, DMCs help protect the safety of patients and the validity of clinical trial results by providing independent review of safety and efficacy data collected during clinical research.

Prometrika and BBCR will help sponsors recruit DMC participants, develop DMC charters and analysis plans, prepare reports and coordinate DMC meetings. The companies will also offer independent statistical analysis of data and safety monitoring.

 “While Prometrika has served as the data analysis center for a number of DMCs during the past seven years, our new DMC service is uniquely positioned to deliver the levels of precision, flexibility and independence that biopharmaceutical companies need to support the full range of requirements for safety monitoring and interim data analysis in clinical research,” said Miganush Stepanians, Ph.D., president and CEO of Prometrika.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.